Keyrus Biopharma, a contract research organization operating in Europe and part of the Keyrus Group, has standardized on Oracle Clinical and Oracle Database to help increase efficiency in clinical trial data collection, improve data quality and security, and support the organization’s European expansion plans.
Hatchtech Pty Ltd confirms a successful Phase 2a clinical trial evaluating DeOvo, an investigational proprietary drug being developed as a new topical treatment for head lice infestation.
The US Food and Drug Administration has given clearance to Melbourne’s Clinuvel Pharmaceuticals to commence a Phase 2 study of its drug, afamelanotide, in up to 60 patients diagnosed with the rare light intolerance erythropoietic protoporphyria (EPP).
In gastric cancer patients who have had part or all of their stomach removed, the hormone ghrelin may lessen post-operative weight loss and improve appetite, according to a new study in Gastroenterology, the official journal of the American Gastroenterological Association (AGA) Institute.
The "vegetable lamb" plant — once believed to bear fruit that ripened into a living baby sheep — produces substances that show promise in laboratory experiments as new treatments for osteoporosis, the bone-thinning disease.
A former Food and Drug Administration scientist said his job was eliminated after he raised concerns about the risks of radiation exposure from high-grade medical scanning.
So a scientist walks into a shopping mall to watch people laugh. There's no punchline. Laughter is a serious scientific subject, one that researchers are still trying to figure out.
Esco CelCulture CO2 Incubators provide a carefully monitored and consistent cell culture environment. VivoCell temperature, CO2 and humidity control technology with proprietary control algorithms, provides cells with a pseudo-in vivo environment by ensuring excellent accuracy and uniformity.
InVitria’s launch of Zap-Hybridoma provides a powerful solution for hybridoma cell culture. Zap-Hybridoma was created to improve monoclonal antibody productivity and deliver easier purification of the target product.
Available in two sizes, the new triple gas incubators from IKS offer a high quality culturing environment with excellent temperature accuracy and CO2 stability.
Isis Pharmaceuticals Inc. said it will work with British drugmaker GlaxoSmithKline PLC to develop treatments for rare diseases in a partnership that could bring Isis almost $1.5 billion in payments.
Nikon Instruments, Inc. has unveiled its new A1R-MP Multiphoton and Confocal microscope system for high speed, high resolution and high sensitivity multiphoton excitation and confocal fluorescence imaging.
TTP LabTech’s comPOUND system consists of a high-density, self-contained, automated sample store and a suite of specialised delivery modules.
A drug already in clinical trials to treat a variety of tumors shows a remarkable ability to shut down growth of glioblastoma in both laboratory cells and in animals.